XT
OM icon

XTX Topco’s Outset Medical OM Stock Holding History

XTX Topco’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Sell
124,690
-17,760
-12% -$77.7K 0.01% 2390
2026
Q1 		$547K Buy
142,450
+41,838
+42% +$171K 0.01% 1973
2025
Q4 		$373K Buy
100,612
+90,313
+877% +$775K 0.01% 1876
2025
Q3 		$145K Sell
10,299
-1,000
-9% -$15.6K 0.01% 1942
2025
Q2 		$217K Buy
+11,299
New +$176K 0.01% 1647
2025
Q1 		– Sell
-3,021
Closed -$50.3K – 2900
2024
Q4 		$50.3K Buy
+3,021
New +$37.7K ﹤0.01% 1895
2024
Q2 		– Sell
-2,695
Closed -$89.8K – 2308
2024
Q1 		$89.8K Buy
2,695
+1,782
+195% +$90.2K 0.01% 1385
2023
Q4 		$74.1K Sell
913
-61
-6% -$4.96K 0.02% 1174
2023
Q3 		$159K Buy
+974
New +$230K 0.03% 1088
2023
Q2 		– Sell
-980
Closed -$270K – 1713
2023
Q1 		$270K Buy
+980
New +$360K 0.06% 735
2021
Q4 		– Sell
-294
Closed -$218K – 912
2021
Q3 		$218K Buy
+294
New +$200K 0.07% 469

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

XTX Topco's OM Position: Q2 2026 in Review

XTX Topco reduced its Outset Medical (OM) stake by 12% in Q2 2026, selling an estimated $77.7K and leaving 124,690 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #2390.

XTX Topco first reported a position in OM in Q3 2021 and has held it in 11 quarters since. The position peaked at $547K in Q1 2026. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • XTX Topco held 124,690 shares of Outset Medical worth $539K as of Q2 2026.
  • XTX Topco sold 17,760 Outset Medical shares in Q2 2026, an estimated $77.7K.
  • Outset Medical made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2390 holding.
  • XTX Topco first reported a position in Outset Medical in Q3 2021 and has held it in 11 quarters since.
  • XTX Topco's Outset Medical position peaked at $547K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.